Phathom Pharmaceuticals, Inc. PHAT Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s total current liabilities?
- Phathom Pharmaceuticals, Inc. (PHAT) reported total current liabilities of $125.04M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s total current liabilities changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s total current liabilities increased by 68.9% year-over-year, from $74.03M to $125.04M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s total current liabilities has grown at a 18.9% compound annual growth rate (CAGR), from $55.52M to $132.04M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.